Susquehanna International Group
BLCM

Susquehanna International Group’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Susquehanna International Group’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,170
Closed -$20K – 11030
2019
Q2 		$20K Buy
+1,170
New +$31.7K ﹤0.01% 10008
2018
Q4 		– Sell
-11,880
Closed -$732K – 10251
2018
Q3 		$732K Buy
11,880
+5,470
+85% +$370K ﹤0.01% 5856
2018
Q2 		$473K Buy
6,410
+960
+18% +$74.8K ﹤0.01% 6904
2018
Q1 		$358K Sell
5,450
-3,550
-39% -$268K ﹤0.01% 7319
2017
Q4 		$757K Buy
9,000
+3,260
+57% +$320K ﹤0.01% 5800
2017
Q3 		$663K Buy
+5,740
New +$604K ﹤0.01% 6028
2017
Q2 		– Sell
-1,340
Closed -$165K – 10017
2017
Q1 		$165K Sell
1,340
-1,230
-48% -$161K ﹤0.01% 8145
2016
Q4 		$350K Sell
2,570
-40
-2% -$7.1K ﹤0.01% 7684
2016
Q3 		$519K Buy
2,610
+940
+56% +$162K ﹤0.01% 5990
2016
Q2 		$216K Buy
+1,670
New +$186K ﹤0.01% 7484
2016
Q1 		– Sell
-1,470
Closed -$298K – 9859
2015
Q4 		$298K Sell
1,470
-6,350
-81% -$1.14M ﹤0.01% 7702
2015
Q3 		$1.14M Buy
7,820
+5,150
+193% +$945K ﹤0.01% 5461
2015
Q2 		$568K Buy
+2,670
New +$655K ﹤0.01% 7366

Other funds holding BLCM

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
PGAM
Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

Susquehanna International Group's BLCM Position: Q2 2023 in Review

Susquehanna International Group sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q2 2023, closing a stake of 30,177 shares — an estimated $9.96K sold.

Susquehanna International Group first reported a position in BLCM in Q1 2015 and held it in 23 quarters. The position peaked at $4.28M in Q3 2017. 4 funds tracked by Wall St. Rank hold BLCM as of Q2 2023.

  • Susquehanna International Group reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 30,177 Bellicum Pharmaceuticals, Inc. shares in Q2 2023, an estimated $9.96K.
  • Susquehanna International Group first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2015 and held it in 23 quarters.
  • Susquehanna International Group's Bellicum Pharmaceuticals, Inc. position peaked at $4.28M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.